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neuroprosthetics community has developed a wide range of highly 
sophisticated stimulating and recording devices and demonstrated 
their efﬁ  cacy with primate and human trials.
This article presents a brief review of challenges faced by cur-
rent neuroprosthetics technology within the context of the device–
  nervous system interface and CNS implants. The complexity of 
the neural tissue response to implantation is described from the 
perspective of neuroprosthetics as well as that of neurobiology. 
These descriptions provide a framework within which speciﬁ  c areas 
of synergy between neuroprosthetics, tissue engineering, and neu-
robiology are discussed. These areas of synergy include in vitro 
models of gliosis and brain injury, nerve regeneration strategies, 
and neural stem/progenitor cell (NPC) biology.
ELECTRICAL INTERFACE CHALLENGES IN NEURAL IMPLANTS
The primary concern in translating neuroprosthetic technology 
from laboratory settings to the clinic is the degradation of electrode 
performance over time. A recent review by Schwartz has suggested 
that on an average, a chronic electrode implanted in monkey cortex 
has only about 40–60% probability of recording activity with the 
exception of the most resilient animal or the electrode that sustains 
several months to years of good recording (Schwartz, 2004). The 
signal attenuation of implanted neuroelectrodes in chronic settings 
occurs primarily due to the biological response of host brain tissue 
to implanted foreign material, i.e., reactive gliosis (Rousche and 
Normann, 1998; Liu et al., 1999; Nicolelis et al., 2003; see Polikov 
INTRODUCTION
Neuroprosthetic device technology has seen major advances in 
recent years but the full potential of these devices remains unreal-
ized due to outstanding challenges, such as the ability to record 
consistently over long periods of time. Existing data relates this 
signal reliability problem to an intrinsic host tissue response upon 
neuroelectrode implantation, namely glial scarring or gliosis, which 
involves a complex series of events that occur following implan-
tation and whose effects inﬂ  uence device performance over long 
periods of time. The fabrication, implantation, and operation of 
neuroprosthetic devices are all highly complex areas in their own 
right and the major advances made to date in neuroprosthetics, 
such as the BrainGate® system developed by Cyberkinetics Corp. 
(Figure 1) and the Boston Retinal Implant Project (Winter et al., 
2007a), are a testament to the success of numerous interdisciplinary 
collaborations. However, the complex biological interface between 
neuroprosthetic devices and the nervous system is still not com-
pletely understood, presenting both challenges as well as opportuni-
ties. Historical divisions have existed between research communities 
in neurobiology, tissue engineering, and neuroprosthetics but each 
discipline stands to beneﬁ  t from the contributions of the other. 
For example, the neurobiology community has developed several 
in vivo and in vitro models to elucidate mechanistic aspects of 
central nervous system (CNS) wound healing. The tissue engineer-
ing community has devised tools to regenerate tissue using novel 
three-dimensional (3-D) constructs, scaffolds, and  bioreactors. The 
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et al.,  2005 for a comprehensive review). Several groups have 
reported gradual attenuation of electrical signals over a period of 
a few days to months after implantation (Rousche and Normann, 
1998; Liu et al., 1999, 2006; Williams et al., 1999; Nicolelis et al., 
2003; Hochberg et al., 2006).
To address this problem, future generations of neuroelectrodes 
are being designed with the aim of reducing tissue encapsulation 
and improving long-term device utilization. Although such engi-
neered probes/models show better success rates in vitro (Massia and 
Hubbell, 1990; Ignatius et al., 1998; Saneinejad and Shoichet, 1998; 
Tong and Shoichet, 1998, 2001; Cui et al., 2001; Webb et al., 2001; 
Kapur and Shoichet, 2003; Moore et al., 2006; Gomez and Schmidt, 
2007; Gomez et al., 2007; Achyuta et al., 2009), animal studies have 
shown that engineered probes elicit similar host tissue response 
chronically, compared to their un-modiﬁ  ed cohorts. The eventual 
result is signal degradation over time (Cui et al., 2003; Ludwig et al., 
2006). For example, in vivo studies in rats conducted on polypyr-
role/peptide coated neural probes failed to record signals following 
2 weeks of implantation (Cui et al., 2003). In another study by 
Ludwig et al. (2006), chronic recordings in rats with electrodes 
coated with poly(3,4-ethylenedioxythiophene) (PEDOT; a conduct-
ing polymer) (Groenendaal et al., 2000) showed lower   impedance 
FIGURE 1 | The BrainGate® neural interface system created by 
Cyberkinetics Corp described by Hochberg et al. (2006). (A) Shows the 
device assembly consisting of the sensor resting on a U.S. penny, a 13-cm 
ribbon cable, and a percutaneous titanium pedestal which is secured to the 
skull. (B) Scanning electron micrograph of the probe, which is a 100-
electrode Utah Array. (C) T1-weighted brain MRI of a tetraplegic patient 
showing the approximate location of the sensor implant site. (D) The ﬁ  rst 
participant in the device trial showing complete external instrumentation of 
the BrainGate® system which allows him to move a computer mouse pointer 
on a screen toward the orange square directed solely by intent. Reprinted by 
permission from Macmillan Publishers Ltd: Nature 442, 164–171, 
copyright 2006.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  3
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initially, but gradually matched that of the uncoated probe, yet 
again indicating signal attenuation with time (Ludwig et al., 2006). 
Figure 2 shows a quantitative illustration of the increase in imped-
ance over time observed by Williams et al. (2007) using microwire 
electrode arrays implanted in rat cortices.
Immune rejection and reactive gliosis are not the only reasons for 
the electrode performance drop over time. For instance, Hochberg 
et al. (2006) (Figure 1) reported failure of recording in a human 
subject after 6.5 months of implantation due to physical short 
circuiting of the electrodes, cable and/or the connector to ground. 
In the same report, following 10 months of successful recording in 
a 55-year-old second human subject, an abrupt signal loss owing to 
an unknown technical problem resulted in the termination of the 
trial. In another report by Williams et al. (1999) loosening of skull 
cap (that keeps the electrode in place) was observed along with 
medical complications leading to failure of recording capability 
within 15–25 weeks of implantation. In addition, since the posi-
tion of most neuroelectrodes is ﬁ  xed with respect to the cortical 
surface, device micro-motion may lead to movement of the device 
to a different cortical area or into the white matter leading to signal 
loss over time (Williams et al., 1999; Schwartz, 2004; Zhong and 
Bellamkonda, 2008). These failures serve as potent motivators to 
rethink and re-examine the signal recording reliability problem 
because successful implantation in patients would require probes 
to record consistently over decades (Nicolelis and Ribeiro, 2002).
BIOLOGICAL RESPONSE TO NEUROPROSTHETIC DEVICES
The conventional view of host response to implanted neuropros-
thetics centers on an acute response, characterized by injury, inﬂ  am-
mation and microglial activation, followed by a chronic response, 
which terminates in the formation of an impenetrable glial/ﬁ  brotic 
scar around the implant. A schematic overview of the glial scar 
formation process is shown in Figure 3. These responses are highly 
complex because the activity and organization of key biological 
mediators of the host response are dynamic (see examples in 
Table 1) and depend on the type and location of implant. This 
section   provides an overview of these responses (Sections “Acute 
Response to Neuroprosthetic Implants,” “Chronic Response to 
Neuroprosthetic Implants,” and “Effects of Implantation Procedure 
on Biological Response”) as well as a discussion of how recent 
ﬁ  ndings from the ﬁ  eld of neurobiology provide additional insights 
into the dynamics and heterogeneity of the CNS scar environ-
ment (Sections “CNS Injury Invokes a Complex Cellular and 
Molecular Response” and “Heterogeneity and Dynamics of the 
Glial Scar Environment”).
ACUTE RESPONSE TO NEUROPROSTHETIC IMPLANTS
The acute response is characterized by formation of a wound by the 
implantation process and the inﬂ  ammatory and attempted wound 
healing responses that follow. The electrode implantation proce-
dure ruptures the blood brain barrier (Zhong and Bellamkonda, 
2008) and disrupts the neurovasculature (Bjornsson et al., 2006), 
causing hypoxia and resulting in the death of glial and neuronal 
cells (Polikov, 2009). Inﬂ  ammation (a normal defense mechanism 
that helps to clear infected, dead, and damaged tissue and return 
it to a normal state) ensues and results in the activation of micro-
glia, astrocytes and inﬁ  ltrated peripheral macrophages. Once acti-
vated, these cells secrete a number of beneﬁ  cial and harmful factors, 
including cytokines, chemokines, neurotransmitters and reactive 
oxygen species (for a comprehensive review, see Whitney et al., 
2009). As a result of the initial mechanical trauma and inﬂ  amma-
tion, swelling of the tissue may also occur (Black, 1999; Ludwig 
et al., 2006) resulting in the displacement of neighboring neurons 
away from the electrode surface (Biran et al., 2005). In addition, 
the blood brain barrier rupture causes blood components such 
as leukocytes and platelets (Polikov et al., 2005) to inﬁ  ltrate into 
the CNS along with serum components (Nadal et al., 1997) and 
cytokines (Balasingam et al., 1994; Raivich et al., 1999) that actively 
participate in inﬂ  ammatory and wound healing processes (Fitch 
and Silver, 1997; Fawcett and Asher, 1999). These initial events 
FIGURE 2 | Tissue reaction against implanted neural electrodes eliciting 
minor gliosis (shown as dotted blue line) and exacerbated gliosis (shown 
as solid red line) in a rat in vivo system quantiﬁ  ed (via impedance 
spectroscopy) by Williams et al. (2007). In the ﬁ  gure, (A) and (B) represent the 
real (R) and imaginary (X) components of complex impedance. The asterisks 
denote the days where impedance values were signiﬁ  cantly different between 
the groups (p < 0.05). Reproduced from Williams et al. (2007) with permission 
from IOP Publishing.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  4
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result in altered basal synaptic transmission and plasticity (Dityatev 
et  al., 2008; Kawasaki et  al., 2008) and are exacerbated by the 
large mismatch in the elastic modulus of the silicon (widely-used 
probe material; ∼100 GPa) and brain tissue (∼100 kPa) (Miller and 
Chinzei, 2002). Furthermore, due to the presence of necrotic tissue 
following insertion, the hydrostatic pressure around the implanted 
electrodes is increased, causing edema and adding to the damag-
ing effect resulting from the presence of electrodes (Schmidt et al., 
1993). After about 6–8 days of implantation, the microglia have 
cleared a substantial amount of cellular debris by phagocytosis 
(Giordana et al., 1994; Fujita et al., 1998) and the excess ﬂ  uid due 
to edema is reabsorbed (Stensaas and Stensaas, 1976). These events 
are seen as an acute reaction of the brain tissue to the implanted 
foreign object and can be externally detected in the form of a spike 
in impedance values during the ﬁ  rst few days of recording (Vetter 
et al., 2004; Ludwig et al., 2006).
CHRONIC RESPONSE TO NEUROPROSTHETIC IMPLANTS
Once the acute reaction subsides, the chronic reaction is initiated due 
to the persistent presence of an insoluble foreign material (Landis, 
1994; Fawcett and Asher, 1999; Turner et al., 1999; Szarowski et al., 
2003; Biran et al., 2005; Polikov et al., 2005; Polikov, 2009). This 
reaction is a complex cascade of events characterized by contin-
ued inﬂ  ammation, adhesion of activated microglia on the probe 
surface, astrocyte activation, and the formation of glial/ﬁ  brotic 
scar tissue that surrounds and insulates the probe (Turner et al., 
1999; Szarowski et al., 2003; Polikov et al., 2005; Brazda and Muller, 
2009). Figure 4 shows the characteristic glial scarring response that 
follows after spinal cord injury in a rat.
The ﬁ  rst event that occurs in the chronic reaction, and one 
that probably persists throughout the duration of the presence 
of implant, is the attachment and clustering of microglia on the 
implant surface (Stensaas and Stensaas, 1976; Winn et al., 1989; 
Moﬁ  d et al., 1997; Kao et al., 1999), as shown in Figure 5. This 
attachment is thought to be mediated by the adsorption of serum 
on the implant surface or due to the release of chemo-attract-
ants by serum factors such as monocytes chemotactic protein-1 
(MCP 1) and macrophage inﬂ  ammatory protein (MIP-1) at injury 
sites (Saadoun et al., 2005). Following colonization, these cells try 
to degrade and remove the implant by secreting lytic enzymes and 
reactive oxygen species (Kyrkanides et al., 2001; Takeuchi et al., 
2001). The action of these cells is analogous to that of peripherally 
derived macrophages that fuse into giant multi-nucleated cells to 
degrade foreign objects (Stensaas and Stensaas, 1976). In addition, 
microglia are also known to produce cytokines such as interleukin-1 
(IL-1), interleukin-6 (IL-6) and tumor necrosis   factor-α (TNF-α) 
that may result in astrocyte activation (Merrill and Benveniste, 
1996; John et al., 2005). Furthermore, microglia have been postu-
lated to regulate the production of the basal lamina, a thin sheet 
comprising extracellular matrix (ECM) proteins, that aids in organ-
izing the glial scar (Polikov, 2009). The proteins in this basal lamina 
can act synergistically to present a substrate for cellular attachment 
via laminin and collagen (Alberts et al., 2001).
In addition to the inﬂ  uence of microglia, astrocyte activation 
is also thought to be mediated by blood-borne factors such as 
thrombin and albumin that inﬁ  ltrate the brain during the neuro-
electrode insertion procedure (Logan and Berry, 2002). Following 
activation, the astrocytes begin to proliferate and secrete inhibitory 
molecules such as chondroitin sulfate proteoglycans, ultimately 
leading to an organized, dense sheath around the implant (Fawcett 
and Asher, 1999; Turner et al., 1999; Szarowski et al., 2003; Polikov 
et al., 2005; Polikov, 2009). The ﬁ  nal structure of the glial scar is 
so robust that it prevents any regenerative axon penetration by 
mechanical (Fawcett and Asher, 1999) and chemical (Roitbak and 
Sykova, 1999) means. In fact, a novel hypothesis indicates that 
the formation of glial scar (Liu et al., 1999; Turner et al., 1999) 
and microglial activation (Biran et al., 2005) together result in 
FIGURE 3 | Schematic representation of the cellular response to a 
neuroprosthetic implant. (A) Location of implant featuring a Utah Array, 
ribbon cable and percutaneous pedestal secured to the skull. Dashed box 
represents the location of the close-up views in (B–D). (B) Cellular 
organization prior to device implantation. (C) Acute injury response featuring 
microglia and astrocyte adhesion to the implant surface, as well as a variety of 
cellular responses local to the implant, including acute inﬂ  ammation, 
extravasated red and white blood cells, myelin debris, edema and damaged 
neurons. (D) Chronic injury response to a neuroprosthetic implant featuring 
isomorphic glial scar and neuronal death local to the implant and surrounded 
by anisomorphic glial scar at a distance from the implant. The acute 
inﬂ  ammation has subsided and edema and cellular debris is cleared. 
Meningeal ﬁ  broblasts are not shown, but may contribute a ﬁ  brotic component 
to the scar depending on characteristics of the device and implantation 
procedure. Features are not drawn to scale.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  5
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pushing the neuronal bodies away from the surface of the elec-
trodes (as indicated in Figure 5) thereby increasing the impedance 
over time and leading to signal loss in chronic recordings. More 
recently, McConnell et al. (2009) have proposed that the this loss of 
  connectivity between the neurons and the electrode substrate can 
Table 1 | Representative biomolecules secreted in response to CNS injury*.
CNS cell types  Secreted molecules  ECM components secreted
 Inhibitory Neurotrophic 
Oligodendrocytes and   NI250, MAG, tenascin-R   GDNF (Wilkins et al., 2003)  NG2, chondroitin sulfate proteoglycans
their precursors  (Fawcett and Asher, 1999)   (Rhodes et al., 2006)
Microglia/macrophages  MCP-1, IL -1, IL -6, TNF-α,    NGF , BDNF , NT-3 (Polikov, 2009) Fibronectins  (Kao et al., 2001), 
  reactive oxygen species,    thrombospondin (Chamak et al., 1994)
 glutamate,  IL-1β, IL -3, VEGF   
 ( Liberto et al., 2004; 
  Polikov et al., 2005)
Astrocytes  Vimentin, tenascin, semaphorin 3,   Laminins, N-cadherin, N-CAM, IGF , NGF ,   Chondroitin sulfate proteoglycans, 
 ephrin-B2,  TGF-β1, β2   BDNF , NT-3, ADNF , HGF (Fawcett and Asher,   basal lamina components
  (Fitch and Silver, 2008)  1999; Liberto et al., 2004; Rolls et al., 2009) (Fawcett and Asher, 1999; Polikov, 2009)
Meningeal cells  NG2 proteoglycan   Laminins (Fawcett and Asher, 1999) Collagens,  ﬁ  bronectins, chondroitin sulfate
 ( Fawcett and Asher, 1999)   proteoglycans  (Manwaring et al., 2001)
*For a recent comprehensive reviews, see Brazda and Muller (2009) and Rolls et al. (2009). Note that individual molecules may have both inhibitory as well as 
trophic/outgrowth stimulating domains.
FIGURE 4 | Glial scar ultrastructure within adult rat spinal cord as 
revealed by GFAP staining. (A) Astrocytes in normal uninjured thoracic spinal 
cord. (B) Isomorphic gliosis showing tissue surrounding GFAP positive 
astrocytes (arrows) is much less disturbed following a lacerating injury (out of 
frame). (C) Anisomorphic gliosis showing a dense scar tissue composed of 
activated astrocytes with interlocking processes encapsulating the damaged 
region of CNS (to the left of the frame is a spinal lesion). Scale = 20 µm. 
Figure adapted from McGraw et al. (2001). Copyright 2001 Wiley & Co. 
Reproduced with permission.
FIGURE 5 | Immunoreactive cellular stratiﬁ  cation at the brain-
neuroelectrode interface examined using cell-speciﬁ  c markers in a 
histological section of a rodent brain following a 4-week microlectrode 
implantation. Microglial (ED1+; red) proximity to the immediate vicinity of the 
probe indicates inﬂ  ammation. Scar-like astrocytes (GFAP+; green) with interwoven 
processes indicate anisomorphic gliosis. The area of inﬂ  ammation and intense 
astrocytic reactivity has a reduced number of neurons, indicated by NeuN+ (blue) 
and neuroﬁ  lament+ (purple) cells indicating loss of connectivity between the 
probe and the neurons following 4 weeks of implantation. The neuroelectrode 
position is illustrated by an orange patch on the left side of the image. Reprinted 
from Biran et al. (2005). Copyright 2005, with permission from Elsevier.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  6
Leach et al.  Bridging neuroprosthetics and biology
also result from the progressive degeneration of neurons caused due 
to local chronic inﬂ  ammation similar to the degeneration observed 
in Alzheimer’s disease.
While this review focuses on the injury response of neuronal and 
glial cells to neuroprosthetic implants, it is important to note the 
possible role of ﬁ  broblasts that may inﬁ  ltrate from injured menin-
ges and damaged blood vessels into the device environment (Berry 
et al., 1983; Carbonell and Boya, 1988). These ﬁ  broblasts can further 
contribute to the encapsulation of the device by cellular and ECM 
materials and exacerbate the insulative and barrier properties of 
this scar tissue that compromise device performance and neuro-
nal function. The extent of ﬁ  broblast inﬁ  ltration depends on the 
proximity of the device to the meninges as well as the extent of 
injury caused by the device geometry, implantation procedure and 
implant micro-motion (as described in the next section).
EFFECTS OF IMPLANTATION PROCEDURE ON BIOLOGICAL RESPONSE
The aforementioned events are restricted to the acute and chronic 
response of the brain tissue upon implanting a foreign object. 
However, other factors such as device insertion technique [manual 
(Stensaas and Stensaas, 1976; Liu et al., 1999) or robotic (Maynard 
et al., 2000; Csicsvari et al., 2003; Nicolelis et al., 2003; Szarowski 
et al., 2003)], speed of insertion (Edell et al., 1992; Nicolelis et al., 
2003; Bjornsson et al., 2006), and most importantly, implantation 
approach (Biran et al., 2007) all have been reported to affect the 
biological response signiﬁ  cantly. For instance, Kim et al. (2004) 
elegantly compared the biological response elicited by two 
implantation schemes in rat cortices (Figure 6). The ﬁ  rst scheme 
utilized was transcranial implantation (a practical model with 
respect to neuroelectrodes) of hollow ﬁ  ber membranes (HFMs) 
and the second scheme was intracranial implantation. A crucial 
ﬁ  nding of this study was that transcranially implanted HFMs 
elicited exacerbated inﬂ  ammation and gliosis (as indicated by 
enhanced positive immunoﬂ  uorescence reactivity for ED1 and 
GFAP). Furthermore, elevated ECM deposition and ﬁ  broblastic 
encapsulation were observed around the transcranially implanted 
HFMs. In contrast, intracranial implants (which were completely 
surrounded by brain tissue) elicited mitigated inﬂ  ammation and 
gliosis. Since the transcranially implanted HFMs were in chronic 
contact with the meninges, the authors concluded that ﬁ  brob-
lasts or NPCs had inﬁ  ltrated into the grey matter resulting in an 
intense reaction.
An alternative interpretation to the authors’ observations, 
however, could be that skull-tethered transcranial implants may 
increase the risk of micro-motion thereby intensifying the scar. 
Indeed, recent work by Biran et al. (2007) showed that tethered 
implants showed higher tissue reactivity compared to un-tethered 
cohorts, highlighting the effect of elevated micro-motion forces in 
conventionally implanted neural probes. Moreover, such micro-
motion forces increase the probability of serum release into the 
brain, which has been shown to increase the extent of glial scar-
ring in vitro (Polikov et al., 2009) whereas their absence has been 
shown to elicit diminished glial scarring in vivo (Nadal et al., 1995, 
1997; Raivich et al., 1999). The above ﬁ  ndings from several research 
groups motivate the development of wireless neuroelectrodes or 
strategies to reduce the mechanical mismatch between the neu-
ral probe and the brain parenchyma. Both of the aforementioned 
 strategies are  currently being pursued (Wise et al., 2004; Capadona 
et al., 2008), as discussed in Section “Recent Efforts to Address 
Biological Response in Neural Probe Engineering.”
CNS INJURY INVOKES A COMPLEX CELLULAR AND MOLECULAR 
RESPONSE
As stated above, the host response to implants is a complex, yet 
well-recognized cascade of events characterized by the initiation 
of inﬂ  ammation and microglial activation, and terminating with 
astrocyte activation and formation of an impenetrable glial scar. 
However, the basic knowledge underlying our understanding of 
host response to implants is being challenged by recent ﬁ  ndings 
centered on the cellular and molecular biology of CNS response 
to injury. These ﬁ  ndings question our basic assumptions about the 
types of cells involved, including reactive astrocytes, inﬂ  ammatory 
cells, and stem cells.
The glial scar, rich in reactive astrocytes, is generally considered 
an inhibitory physical and biochemical barrier to axonal growth. 
However, emerging studies indicate that reactive astrocytes can 
play protective roles during the acute injury phase by aiding wound 
healing, protecting and supporting neurons, and limiting second-
ary damage due to uncontrolled inﬂ  ammation, demyelination 
and tissue damage (Bush et al., 1999; Faulkner et al., 2004; Hertz 
and Zielke, 2004; Okada et al., 2006; Renault-Mihara et al., 2008). 
Moreover, depending on the structure of the scar tissue and the 
molecules expressed by the reactive astrocytes, under some cir-
cumstances, reactive astrocytes may support axonal outgrowth (Li 
and Raisman, 1995; Sivron and Schwartz, 1995; Ridet et al., 1997). 
This response may be tied to the nature of the injury (Davies et al., 
1996), the region in the CNS where injury occurred (Alonso and 
Privat, 1993; Li and Raisman, 1995; Malhotra and Shnitka, 2002) 
and factors present in the injury microenvironment (e.g., soluble 
molecules including cytokines, growth factors and serum compo-
nents as well as insoluble components such as ECM and cell surface 
molecules) (Kawaja and Gage, 1991; Li and Raisman, 1995; Ridet 
FIGURE 6 | Intensity of glial scarring in rats based on implantation 
procedure. (A,B) show co-expression analysis of GFAP (red) and vimentin 
(green) of implanted hollow ﬁ  ber membranes (HFMs) in rats via two 
implantation schemes. Vimentin is expressed by astrocytes, microglia and 
ﬁ  broblasts derived from the meninges and other connective tissues. (A) 
Intraparenchymal implant (where the entire implant is surrounded by brain 
tissue) show less vimentin immunoreactivity along with GFAP reactivity. (B) 
Transcranial HFMs show thick layers of GFAP+/vimentin+ cells suggesting 
meningeal ﬁ  broblast inﬁ  ltration due to skull-tethering of HFMs in such 
implants. The same study also showed higher ED1 reactivity in transcranial 
implants compared to intraparenchymal implants highlighting the exacerbated 
gliosis in the former implantation scheme. Scale = 100 µm. Reprinted from 
Kim et al. (2004). Copyright 2003, with permission from Elsevier.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  7
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et al., 1997). As discussed in Section “Heterogeneity and Dynamics 
of the Glial Scar Environment,” the heterogeneous organization and 
temporal dynamics of these components are also key considerations 
for addressing the CNS response to neuroprosthetic implants.
Like glial scar formation, inﬂ  ammation is another response to 
CNS injury that unfortunately is not well understood. In addition 
to clearing damaged tissue, inﬂ  ammation can also cause damage to 
surrounding healthy tissue (Blight, 1994; Fitch and Silver, 1997) and 
inhibit axonal regeneration by promoting the synthesis of inhibi-
tory ECM (Fitch and Silver, 2008); thus inﬂ  ammation is considered 
to be both beneﬁ  cial and detrimental toward the healing of dam-
aged CNS tissue. Indeed, studies that manipulated the population 
or activity of immune cells in sites of CNS injury have drawn con-
ﬂ  icting conclusions as to whether inﬂ  ammation on the whole is 
favorable toward CNS repair (Rapalino et al., 1998; Popovich et al., 
1999). Moreover, the impact of inﬂ  ammation on CNS repair may 
depend on the activation state of the immune cells (Lotan and 
Schwartz, 1994; Rapalino et al., 1998; Fitch and Silver, 2008) and 
the extent to which activated astrocytes (Ridet et al., 1997) and 
native neural stem cells are involved (Butovsky et al., 2006; Das 
and Basu, 2008; Whitney et al., 2009). As our understanding of 
the beneﬁ  cial roles reactive astrocytes and microglia continue to 
be elucidated, the potential power of driving these cell responses 
toward supporting improved neuroprosthetic device performance 
becomes more realistic.
Another area of perhaps even greater versatility is the role of 
NPCs in CNS response to injury and the potential of transplanted 
NPCs to treat areas of damaged or lost neuronal function (for 
comprehensive reviews see Jessell and Sanes, 2000; Goh et al., 2003; 
Zhao et al., 2008). NPCs are capable of differentiating into neurons, 
astrocytes, and oligodendrocytes. Neurogenic NPCs are found in 
the adult mammalian brain in the subventricular zone of the lateral 
ventricles and the subgranular zone of the hippocampus and den-
tate gyrus. When damage or inﬂ  ammation occurs within the brain, 
NPCs are signaled to proliferate and migrate toward the injury 
site (Nait-Oumesmar et al., 1999; Arvidsson et al., 2002; Nakatomi 
et al., 2002; Jin et al., 2003; Goings et al., 2004), and in the case of 
neuroprosthetic implants, NPCs accompany microglia in attaching 
to the device surfaces (Stensaas and Stensaas, 1976; Winn et al., 
1989; Moﬁ  d et al., 1997). These processes are inﬂ  uenced by soluble 
factors as well as cues within the glial scar (Rolls et al., 2009). Along 
these lines, studies involving NPC transplants have indicated that 
priming the cells toward the neuronal fate is required because NPCs 
tend to remain undifferentiated or become glia in non-neurogenic 
implant sites (Fricker et al., 1999; Sheen et al., 1999; Cao et al., 2001; 
Han et al., 2002; Gao et al., 2006; Lepore et al., 2006) and this effect 
is exacerbated in glial scar microenvironments (Cao et al., 2001, 
2002; Faijerson et al., 2006). Inﬂ  ammation is also known to inﬂ  u-
ence NPC response: mild acute inﬂ  ammation can induce neurogen-
esis while uncontrolled and longer-term inﬂ  ammation mediated by 
large numbers of activated microglia can greatly reduce the number 
of newborn neurons (Ekdahl et al., 2003; Butovsky et al., 2006). As 
with the potential beneﬁ  cial roles of astrocytic and microglial cells, 
our ever increasing understanding of how host and transplanted 
NPCs respond in the implant environment has great promise to 
yield potentially powerful mechanisms for improving long-term 
device performance.
In summary, these studies of general CNS response to injury 
underscore the importance of using caution while interpreting the 
cellular and molecular responses that occur in the speciﬁ  c case of 
neuroprosthetic implants in the CNS. Yet, the unraveling of these 
complex cellular responses may provide potential mechanisms to 
drive favorable biological outcomes and result in improved long-
term neuroprosthetic device performance. However, as discussed in 
the next section, the spatial heterogeneity and temporal dynamics 
under which these components interact must also be considered 
in order to better understand the complex CNS tissue response to 
neuroprosthetic implants.
HETEROGENEITY AND DYNAMICS OF THE GLIAL SCAR ENVIRONMENT
Further complicating the current understanding of CNS response 
to injury is the fact that the cellular and molecular response within 
the damaged tissue varies both with time post-injury as well as 
proximity to the wound itself. In terms of temporal dynamics, 
the progression of acute response to implants toward forma-
tion of a glial scar is discussed in Section “Biological Response to 
Neuroprosthetic Devices”; however, the chronic stage response to 
even relatively simple surgical trauma may not terminate with the 
formation of glial scar, but instead proceed 6 months or longer 
after surgery toward further tissue damage via cell lysis and tissue 
disassembly (Frontczak-Baniewicz and Walski, 2006). An example 
of a phenomenon relating to the spatial heterogeneity is the dif-
fusion of secreted cytokines and inﬂ  ammatory factors away from 
the implant site. In fact, cells located at least 0.5 mm away from 
the edge of an implant can be impacted by the diffusion of these 
molecules (Biran et al., 2005), and moreover, the concentration 
proﬁ  le of these factors will change spatially and temporally after 
device implantation.
Perhaps not surprisingly, therefore, two classiﬁ  cations of glial 
scar ultrastructure have been noted to describe the tissue surround-
ing the injury site (Ridet et al., 1997; McGraw et al., 2001) (Figure 4) 
and the type of ultrastructure that predominates depends in part on 
the location and time period relative to tissue injury. Anisomorphic 
gliosis may occur within the immediate area of a traumatic injury 
or chronic implant and is deﬁ  ned by a dense scar tissue composed 
of activated astrocytes with interlocking processes. Anisomorphic 
gliosis results in a permanent disruption to normal tissue archi-
tecture. Isomorphic gliosis occurs in tissues that are much less dis-
turbed, such as in simpler injuries or at locations some distance 
away from the implant site. This less extreme response is character-
ized by astrocyte hypertrophy and may resolve without formation 
of a permanent scar or represent a transition stage to anisomorphic 
gliosis. In other words, the extent of injury inﬂ  uences the dynam-
ics, structure and composition of the glial scar, and as discussed in 
Section “CNS Injury Invokes a Complex Cellular and Molecular 
Response,” in turn also impacts the level of astrocyte and microglial 
activation (Fernaud-Espinosa et al., 1993). Thus, it is becoming 
increasingly apparent that a thorough analysis of CNS response to 
neuroprosthetic device implantation must include multiple tissue 
locations (adjacent to, local to and distant from the device surface) 
as well as multiple acute and chronic time-points.
Studies focused on testing therapeutic treatments for CNS injury 
have begun verify the importance of considering the time-scale of 
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of glial scar formation (McGraw et al., 2001; Rolls et al., 2009). For 
example, therapies targeted toward degrading or preventing the syn-
thesis of inhibitory components of the scar ECM are only effective 
if administration is delayed relative to the initial injury (Rolls et al., 
2008). Comparable effects have been found with timing treatments 
to ablate activated astrocytes (Okada et al., 2006), as astrocytes may 
play a beneﬁ  cial role in the acute stage of tissue repair, but become 
detrimental in the chronic injury state. Similarly, the timing of thera-
peutics aimed toward promoting axonal regeneration and restora-
tion of function should be carefully considered: studies that delayed 
treatment 2–4 weeks after injury (Coumans et al., 2001; Iarikov et al., 
2007) have yielded beneﬁ  ts, as the environment posed by very early 
stages of injury response are associated with necrosis and cytotoxic 
inﬂ  ammatory processes such as edema and the production of reactive 
oxygen species. However, treatment cannot be delayed indeﬁ  nitely 
because once the acute tissue response subsides, the formation of 
dense scar tissue prevents axonal penetration into the injury site. 
Despite these ﬁ  ndings, the timing of therapeutics has not yet been 
adequately considered (McGraw et al., 2001; Gervasi et al., 2008) 
and poses particular challenges for the neuroprosthetics community 
because the timing of the acute and chronic phases depends on the 
type, shape and location of implant. Fundamental studies, such as the 
recent report by Harris et al. (2009) that deﬁ  ne temporal and spatial 
changes in the mRNA levels of inhibitory molecules in the cerebral 
cortex following traumatic brain injury as well as time-course studies 
of neurotrophin and ECM expression (Catapano et al., 2001; Lagord 
et al., 2002; Wang et al., 2007), will greatly beneﬁ  t our understanding 
of the dynamics of these complex processes.
HOST RESPONSE TO RETINAL AND COCHLEAR IMPLANTS
Although this review focuses primarily on the host response to neural 
prostheses implanted in brain tissue, it is important to consider the 
response elicited by other CNS implant systems such as epiretinal, 
subretinal, and cochlear implants. Because of the heterogeneity in 
the microenvironments, inherent differences in microanatomy in the 
vicinity of the implant, and the presence of cell types that are speciﬁ  c 
to the implantation site, speciﬁ  c types of retinal and cochlear devices 
differ in the extent of elicited glial scarring and ﬁ  brotic tissue forma-
tion in vivo (Bertschinger et al., 2008; Swan et al., 2008). With respect 
to subretinal and epiretinal implants, although chronic astrogliosis 
is observed after a few months of implantation (Montezuma et al., 
2006), the extent of scarring is not as intense when compared to 
that of brain tissue mostly due to the absence of microglia and the 
relatively lower density of nerve ﬁ  bers (implying lesser neurotrauma 
post-insertion) (Weiland et al., 2005). In addition, previous work 
has also shown that a special type of NPCs known as “Müller Glia” 
can differentiate into photoreceptor cells following retinal injury 
(Bernardos et al., 2007). Consequently, delivering the appropriate 
growth factors following injury might augment NPC differentiation 
and neural regeneration following retinal prosthesis implantation.
With respect to cochlear implants, the microenvironment not 
only favors the production of a robust ﬁ  brotic scar along with the 
death of spiral ganglion neurons (SGN), but also supports forma-
tion of calciﬁ  ed tissue near the scala tympani in humans (Clark, 
2003). This new bone formation is a part of the healing phase in 
the chronic inﬂ  ammatory response governed by the synergistic 
  activation of cytokines such as ﬁ  broblast growth factor (FGF), 
  insulin-like growth factor (IGF), platelet-derived growth factor 
(PDGF), and transforming growth factor (TGF-β1) which is spe-
ciﬁ  c to the cochlear tissue. Calciﬁ  cation, glial scarring and SGN 
death can increase the impedance of the cochlear electrodes analo-
gous to the impedance increase encountered by neural prostheses 
implanted in the brain. However, recent work by Richardson et al. 
(2009) has shown that delivering the trophic support of brain-
derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) 
along with electrical stimulation would augment the SGN survival 
and chronic activity of cochlear implants, in vivo; this approach of 
trophic factor delivery is analogous to approaches being pursued 
with neural implants in the brain, as discussed below.
RECENT EFFORTS TO ADDRESS BIOLOGICAL RESPONSE IN 
NEURAL PROBE ENGINEERING
Future-generation neural prosthetic devices are being designed 
with a greater emphasis on reducing the tissue encapsulation 
problem to ensure consistent recordings in clinical settings. Some 
of the most promising work conducted in alleviating the glial 
scar problem has included bioactive coatings, reducing mechani-
cal mismatch between the probe-brain interfaces and developing 
wireless implantable neuroelectrodes (see Table 2). For instance, 
Webb et al. (2001) immobilized a neural cell adhesion molecule 
(L1-NCAM) on glass substrates and showed in vitro that these bio-
active coatings attract primary CNS neurons and support neurite 
outgrowth while repelling primary astrocytes, meningeal cells and 
ﬁ  broblasts. However, one of the limitations of this work was that 
the study did not include microglia, the frontline responder cells, 
to completely validate their model. Another bioactive coating 
strategy was developed by He et al. (2007) with an immobilized 
anti-inﬂ  ammatory tridecapeptide, α-MSH, on silicon probes, 
demonstrating diminished inﬂ  ammation and gliosis (Figure 7). 
Although this study illustrated exceptionally promising results 
with respect to in vitro as well as in vivo substantiation of the 
bioactivity of the peptide tethered electrodes, the group did not 
evaluate or show results pertaining to neuronal loss around the 
electrodes, which has been a major impediment to obtaining 
chronic consistent recordings (Biran et  al., 2005). Cell-based 
bioactive coatings on neural probes have also been examined; 
Schlosshauer et al. (2001) encapsulated rat Schwann cells within 
a ﬁ  brin gel and placed the gel in contact with a slice of rat spinal 
cord adhered to a neural probe. To simulate a glial scar, ﬁ  broblasts 
were pre-adhered onto the probe, which had sieves in the size 
range of 40–70 µm. With this arrangement, the authors observed 
marked neurite penetration of the sieves relative to controls with 
no Schwann cells.
With respect to minimizing micro-motion, a recent review by 
Wise et al. (2004) discusses a wide range of wireless implantable 
devices that have been developed in recent years; hence a transition 
from transcranial designs to intracranial device designs is feasible 
if the latter can be shown to mitigate the tissue response, as sug-
gested by the work of Tresco and colleagues (Kim et al., 2004; Biran 
et al., 2007). On the other hand, with regard to stimulus-responsive 
materials, recent work by Capadona et al. (2008) describes a coat-
ing material for probes that can exhibit a solvent-induced change 
in elastic modulus, analogous to tissues found in sea cucumber 
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BRIDGING THE DIVIDE: TISSUE ENGINEERING TECHNOLOGIES 
TO ADVANCE NEUROPROSTHETICS
As discussed above, critical challenges face the neuroprosthet-
ics ﬁ  eld, and thus far, these challenges have been addressed with 
materials science innovations or single-factor means to augment 
biocompatibility. Meanwhile, neurobiologists have made signiﬁ  -
cant strides in understanding the complexity of how CNS tissue 
responds to injury. Great promise therefore exists in the possibility 
of bridging the divide between the neuroprosthetics and neurobio-
logical communities, but how can this be best accomplished? Even 
if we knew the complete neurobiological response to injury and 
chronic implantation, how could we use this knowledge to make 
improved neuroprosthetic devices? How do we reconcile the fact 
that understanding the biological response is paramount, yet the 
CNS response to injury is so intricate that we may not ever have 
adequate technology and control over the biological response to 
seamlessly integrate a neuroprosthetic device into undisturbed 
CNS tissue?
We argue that tissue engineering technologies are well-poised 
to address these challenges by bridging the technological and 
biological intricacies of this complex problem. Tools recently 
developed in the tissue engineering community are helping to 
deﬁ  ne how multifactorial cues determine cell response and pro-
viding mechanisms to harness the body’s inherent regenerative 
potential. As discussed below, these tools include (1) platforms 
that present two or more simultaneous substrate cues via pat-
terning of co-cultured cells, substrate topography and adhesive 
biomolecules; (2) controlled delivery of soluble bioactive mol-
ecules; and (3) constructs and biomimetic tissue models that are 
created via advances in hydrogel chemistry, 3-D patterning, and 
3-D culture. This section concludes with the highlight of several 
issues on the frontier of neural and cancer cell biology and sug-
gestions for how tissue engineering principles could apply these 
new insights toward new experimental and therapeutic neuro-
prosthetic technologies.
Table 2 | Highlights of efforts to address biological response in neural probe engineering.
Goal Approach  Reference
Enhance neuronal adhesion while inhibiting   Immobilized neural cell adhesion   Webb et al. (2001)
astrocyte and meningeal cell adhesion  molecule L1-NCAM on SiO2 surfaces
Mitigate astrocyte and microglial reaction  Immobilized anti-inﬂ  ammatory tridecapeptide (α-MSH) on   He et al. (2007)
  single shank planar electrodes
Achieve solvent-induced change in elastic modulus  Water-based stimuli responsive cellulose nanoﬁ  bers   Capadona et al. (2008)
  embedded in a matrix formed from ethylene
  oxide epichlorohydrin or poly (vinylacetate)
Fabricate multi-functional neural electrodes   Silicon probe coated with biodegradable nanoﬁ  bers of   Abidian and Martin (2009)
with low impedance, reduced mechanical  PLGA loaded with dexamethasone followed by a coat
mismatch between electrode-tissue interface  of alginate gel to induce slow drug release. PEDOT
and drug releasing properties  electrochemically polymerized onto electrode sites around
  PLGA within the alginate gel to reduce impedance
Fabricate neuroprosthetic device with microﬂ  uidic channels   3-D probe structures (micron-sized channels)   Retterer et al. (2004)
for biomolecule release to reduce tissue reaction  fabricated using surface micromachining and
  DRIE techniques to facilitate diffusion-mediated
  delivery of transferrin in vivo
FIGURE 7 | GFAP reactivity of uncoated silicon microelectrodes (G, J) and 
an anti-inﬂ  ammatory peptide (α-MSH) tethered electrode (H, K) 
following 1 week and 4 weeks of implantation in rats. The α-MSH coated 
electrodes elicited mitigated astrocytic and microglial reactivity (not shown 
here) indicating bioactivity of the coated implant. Scale Bar = 100 µm. Images 
reprinted from He et al. (2007). Copyright Wiley-VCH Verlag GmbH & Co. 
KGaA 2007 . Reproduced with permission.
report by Bellamkonda (2008) indicates that, the total range of 
elastic modulus is modest and the softest state was actually far 
from the required modulus for camouﬂ  aging a probe implanted 
in brain tissue.
The aforementioned studies have showed tremendous potential 
to improve the reliability of chronic recordings in neural probes. 
Nevertheless, very few studies to date have effectively incorporated 
and implemented designs in a functional neuroprosthetic device 
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PLATFORMS TO PRESENT CELLS WITH MULTIPLE SUBSTRATE CUES
Modifying the implant surface is one simple means to determine 
how cells respond to the foreign surfaces presented by neuropros-
thetic devices in the implant site. Indeed, a variety of surfaces 
have been explored, as described in Sections “Electrical Interface 
Challenges in Neural Implants” and “Recent Efforts to Address 
Biological Response in Neural probe Engineering.” However, these 
cues are typically presented individually to cells and it is likely that 
once the cue is masked by serum deposition or scar tissue, it will be 
rendered ineffective. Therefore, a multifunctional approach may 
provide advantages toward directing speciﬁ  c cellular responses. For 
example, separate works by the Hoffman-Kim and Tresco groups 
have demonstrated co-culture techniques for initiating patterns of 
glial cells that subsequently prove effective for guiding neuronal 
adhesion and neurite outgrowth (Biran et al., 2003; Bruder et al., 
2007). While originally reported as tools to augment spinal cord 
and peripheral nerve regeneration, these approaches may prove to 
be useful for direct application to neuroprosthetic devices as well 
as in vitro studies of the molecular mechanisms by which glial cells 
affect neuronal response.
Another multifunctional surface modiﬁ  cation approach that 
may have direct implications for neuroprosthetic devices is one 
that presents cells with topographical cues as well as patterned 
biomolecules that support cell adhesion. The essential goal of 
this approach is to mimic both the physical and the biochemi-
cal aspects of ECM that are favorable for neurite outgrowth. One 
example comprises electrospun polyamide nanoﬁ  brillar surfaces 
that are covalently bound with peptides derived from tenascin-C 
(a neuroactive component of the ECM); these surfaces signiﬁ  cantly 
enhanced neuronal adhesion and neurite outgrowth in vitro as 
compared to glass coverslips or nanoﬁ  bers modiﬁ  ed only with 
poly-l-lysine (a common and relatively simple biomolecule that 
supports neuronal adhesion) (Ahmed et al., 2006). Similarly, to 
develop a model to investigate neuronal development, Li and Folch 
(2005) generated substrates that vary with microtopography and 
ability to support neurite outgrowth. This model was composed of 
microfabricated ridges of polydimethylsiloxane that were coated 
with poly-d-lysine, seeded with neurons and then covered with 
Matrigel, a gel matrix that supports cell and neurite inﬁ  ltration. 
This study showed that axons decide where to grow by integrating 
permissiveness and topographical cues that are presented in the 
neuron’s 3-D microenvironment. Such strategies to understand 
how cells respond to multiple substrate factors may prove useful 
in determining which kinds of device properties are most impor-
tant in promoting neuronal viability and neurite growth toward 
neuroprosthetic devices while ameliorating inhibitory responses 
from glia and immune cells in the implant site.
Although the above mentioned routes of administering multiple 
cues to cells have enhanced our fundamental understanding of neu-
roglial interactions and embryonic development, translating these 
technologies toward chronic and consistent recordings of neuro-
prosthetic devices would still prove to be an arduous challenge. 
Such a limitation stems from the fact that all the aforementioned 
technologies utilize embryonic neurons for their studies; how-
ever, the adult nervous system comprises of post-mitotic neurons 
(McMillian et al., 1994; Wu and Schwartz, 1998). Therefore, it is not 
apparent if presenting multiple cues on neural probe surfaces will 
produce neurite outgrowth in adult neurons and result in extensive 
neuronal networks with greater proximity to implanted electrodes 
and chronic activity.
DELIVERY OF SOLUBLE BIOACTIVE MOLECULES AND CELLS
In addition to substrate cues, soluble bioactive molecules are a 
powerful means to inﬂ  uence cell response in the implant envi-
ronment. To be successful, this approach must apply the appro-
priate individual or cocktail of factors with suitable dosing (i.e., 
concentration, timing, and location). Neuroprosthetic engineers 
have begun to explore this approach by incorporating microﬂ  u-
idic channels into devices (Chen et al., 1997, 2008; Lee et al., 2004; 
Retterer et al., 2004; Takeuchi et al., 2005; Papageorgiou et al., 2006; 
Mercanzini et al., 2008) or implementing surfaces modiﬁ  ed with 
a controlled-release matrix loaded with drug (Klaver and Caplan, 
2007; Winter et al., 2007b; Jun et al., 2008; Abidian and Martin, 
2009; Jhaveri et al., 2009). Recent studies from the research group of 
David Martin (Abidian and Martin, 2009; Abidian et al., 2009) have 
elegantly illustrated the potential of multifunctional surface coat-
ings on neural probes (Figure 8). In this work, a silicon probe was 
ﬁ  rst coated with biodegradable nanoﬁ  bers of poly(lactic-co-gly-
colic acid) (PLGA) loaded with dexamethasone, a neuroprotective 
molecule. This layer was encapsulated within an alginate hydro-
gel. In the ﬁ  nal step of coating assembly, a conducting polymer, 
PEDOT, was electrochemically polymerized onto the electrode sites 
on the probe and around the PLGA nanoﬁ  bers; this polymerization 
occurred within the alginate hydrogel. The PEDOT coating effec-
tively increases the surface area available to neurons for electrical 
connectivity while the PLGA provides controlled release of the neu-
roprotective drug. Implant studies in rat barrel cortex using a form 
of this device manufactured with PEDOT nanotubes demonstrated 
improved signal-to-noise ratios, lower electrode impedance, and 
higher charge capacity density, as well as the abilities to function 
in chronic (7 weeks) recording applications and sense the transi-
tion from acute inﬂ  ammation to chronic response (Abidian et al., 
2009). Though the controlled release aspect of these devices was 
not yet tested in vivo, these promising results highlight the potential 
of such multifunctional approaches toward achieving improved 
neuroprosthetic device performance in chronic applications.
However, challenges remain in ensuring that the molecules 
are released at the appropriate time and place to treat the com-
plex cascade of cellular responses following implantation and 
maintain long-term release of bioactive molecules in chronic 
implants. Fortunately, similar requirements have been identi-
ﬁ  ed in other tissue engineering applications and several poten-
tial strategies exist to meet these challenges. Examples include 
materials that are “cell-responsive” by degrading upon exposure 
to cell-secreted enzymes (Lutolf et al., 2003) and materials that 
control the release of bioactive factors via similar mechanisms 
used by the ECM sequester and release growth factors (Tanihara 
et al., 2001; Ohta et al., 2004). Materials chemistry and process-
ing can also be manipulated to preprogram separate release rates 
of multiple bioactive factors (Richardson et al., 2001; Holland 
et al., 2005; Park et al., 2007). Finally, another means to provide 
biological sophistication to the delivery of bioactive molecules 
is to use a cell-based approach. Cells respond to external stimuli, 
can secrete molecules for long time periods, and can manufacture Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  11
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molecules that would be impractical or impossible to produce 
and purify ex vivo. Cell-based drug delivery approaches are often 
implemented by encapsulating cells in a hydrogel depot to protect 
the cells and further control the biomolecule release. (For recent 
comprehensive reviews on controlled release of biomolecules and 
cell-based drug delivery, see Schmidt et al., 2008; Lin and Anseth, 
2009; Silva et al., 2009.) Thus a multifunctional device design that 
utilizes our growing understanding of astrocyte, microglial and 
NPC cell response to drive cell-based delivery of bioactive factors 
could be a potentially powerful means to control CNS response 
to long-term neuroprosthetic implants.
Delivery of NPC cells along with neuroprosthetic devices may 
provide trophic support to local neurons, or perhaps even replace 
dead neurons and replace host circuitry. One particularly daunting 
challenge that may be addressed by this approach is the progressive 
neuronal degeneration following chronic implantation of neural 
prosthetic devices. Recent work by Englund et al. (2002) has shown 
that delivering a multipotent progenitor cell line known as RN33B 
into postnatal day 1–2 rat neural tissue can produce functional cor-
tical networks even after host neurogenesis is complete and in brain 
areas outside the classical neurogenic regions. However, it is also 
known that the extent of neurogenesis of progenitor cell types such 
as RN33B differs greatly between different brain regions (Lundberg 
et al., 2002) even though this cell type has natural propensity to dif-
ferentiate into functional neurons in vitro as well as in vivo (Onifer 
et al., 1993; Whittemore and White, 1993; Shihabuddin et al., 1996). 
Hence it is not clear whether foreign cells would have sufﬁ  cient 
survival or even invoke aberrant synaptic activity after incorpora-
tion into the host circuitry.
3-D CONSTRUCTS AND BIOMIMETIC TISSUE MODELS
It is well recognized that a static monolayer culture has a limited 
capability to recapitulate the in vivo microenvironment; for exam-
ple, in a 1999 review, Fawcett and Asher (1999) conclude that much 
of the astrocyte literature, and in particular, the studies relating 
to whether astrocytes aid or inhibit axonal growth, is confusing 
largely because current in vitro model systems are limited in their 
ability to mimic the in vivo scenario. Indeed, in the last decade, 
cell biologists and tissue engineers have made rapid progress in 
deﬁ  ning the cellular and molecular basis for how cells respond 
to culture dimensionality (2-D vs 3-D) (Cukierman et al., 2001; 
Pampaloni et al., 2007; Tibbitt and Anseth, 2009) and mechanical 
stimuli (Chen, 2008; Wang et al., 2009a) and are developing in vitro 
model systems that more faithfully represent in vivo conditions. 
Key criteria for in vitro models of CNS are discussed below and 
include, (1) biologically-relevant scaffolding materials; (2) most or 
all of the relevant cell types, namely neurons, astrocytes, microglia, 
endothelial cells and meningeal ﬁ  broblasts; and (3) appropriate 
spatial arrangement of the scaffolding materials and cells.
Because the ECM plays a role in cell response to injury, it is 
important to carefully consider the scaffolding material selected 
for in vitro models of CNS. Three-dimensional culture studies have 
demonstrated that neurons can survive and grow neurites within 
scaffolds composed of agarose, type I collagen, ﬁ  brin, and Matrigel 
to name a few (O’Connor et al., 2001; Gingras et al., 2003; Suuronen 
et al., 2004; LaPlaca et al., 2005; Lin et al., 2005). The ECM of the 
CNS is composed primarily of laminin, type IV collagen, and 
various proteoglycans and glycosaminoglycans such as hyaluro-
nan, tenascins, and heparan sulfate proteoglycans (Venstrom and 
Reichardt, 1993; Fitch and Silver, 2008; Hubert et al., 2009). The 
distribution of these molecules changes during periods of axonal 
growth, such as in development, as compared to physiological levels 
in adults. The ECM of injured CNS tissue and glial scar, however, 
contains increased amounts of proteoglycans (e.g., chondroitin 
sulfate) as well as components resulting from damage to the vas-
culature and dura mater, such as ﬁ  brin, ﬁ  bronectin and type I 
collagen. Because many of these molecules directly or indirectly 
impact neuronal behavior, it is very important select a scaffolding 
material with greatest relevance to the biological or pathological 
scenario of interest.
Of particular relevance to neuroprosthetic devices are studies 
carried out by three groups with the intent of developing in vitro 
co-culture models of neuronal response to glial scar resulting from 
microelectrode implantation and mechanical injury. First, stud-
ies by Polikov and Reichert adapted an established in vitro model 
of neuroinﬂ  ammatory response toward the investigation of glial 
response to microelectrode implantation (Polikov et al., 2006, 2009) 
(Figure 9). This model system consists of a conﬂ  uent layer of neu-
rons, astrocytes and microglia that are derived from embryonic 
rat midbrain. An injury was induced to the culture by scraping 
away a section of the cells and/or placing a foreign body (50 µm 
diameter stainless steel wire) on top of the cells. The cultures were 
assessed at 6 h and 10 days after injury by immunocytochemical 
staining for markers for neurons and reactive forms of astrocytes 
and microglia. Their initial report found that the developed in vitro 
model compared favorably to in vivo response to injury in the 
brain (Polikov et al., 2006), whereas their follow-up report focused 
FIGURE 8 | (A–D) Design of a multi-functional neural probe with low 
impedance and controlled drug-release capability. A planar Michigan probe is 
ﬁ  rst coated with biodegradable nanoﬁ  bers that are pre-loaded loaded with 
dexamethasone, an anti-inﬂ  ammatory drug. An alginate gel overcoat ensures 
slow drug release. Within the gel, a conducting material PEDOT is 
electrochemically polymerized from the electrode sites. (E) Two different 
compositions of nanoﬁ  bers are examined, poly(lactic acid) and poly(lactic-co-
glycolic acid) and the inclusion of the alginate gel overcoat (HG) is shown to 
signiﬁ  cantly slow down the release of dexamethasone. All images reprinted 
from Abidian and Martin (2009). Copyright Wiley-VCH Verlag GmbH & Co. 
KGaA 2009. Reproduced with permission.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  12
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on   improving the reproducibility of the model system via opti-
mized culture conditions and established a quantitative method for 
interpreting the results (Polikov et al., 2009). Because this model 
system was carefully designed to account for multiple cell types 
and provides a mechanism to rigorously compare different types 
of injuries and implant materials, this approach has great potential 
for unveiling fundamental mechanisms of glial scar formation and 
neuroprosthetic performance.
Second, Wanner et al. (2008) developed a model of mechanical 
injury to investigate the roles of astrocyte activation and meningeal 
ﬁ  broblasts in neuronal response (Figure 10). Newborn rat astrocytes 
with and without meningeal ﬁ  broblasts were grown on deformable 
silastic membrane and were exposed to two short pulses of stretch 
to mimic mechanical injury. Neurons derived from the cortex, spinal 
cord and dorsal root ganglia of postnatal and embryonic rat were 
seeded on the astrocyte cultures. The investigators found that stretch 
injury activated the astrocytes, resulting in signiﬁ  cantly reduced neu-
rite outgrowth compared to unstretched cultures. Interestingly, the 
extents of neurite outgrowth varied with age (greater inhibition in 
postnatal vs embryonic neurons) and type of neuronal population. 
This model highlights the importance of considering cell type and age 
when designing in vitro and animal model systems. For example, cell 
activation and the extent of glial scar formation is greatly enhanced 
in adult compared to neonatal animals, but unfortunately, few stud-
ies have focused on the heterogeneity of cell response to injury as a 
function of cell source or age (Ridet et al., 1997).
Third, LaPlaca’s laboratory has developed an in vitro model for 
traumatic brain injury that is based on rat embryonic astrocytes and 
rat postnatal cortical neurons that are co-cultured within Matrigel 
constructs and either exposed to controlled shear (LaPlaca et al., 
2005) or injected with NPCs to mimic damage inﬂ  icted during cell 
transplantation (Cullen et al., 2007). These culture platforms were 
able to support neuronal viability and neurite outgrowth for up 
to 3 weeks; interestingly, at the beginning of culture, the astrocyte:
neuron ratio was 1:1, but at later time periods, this ratio became 
9:1 and was suggested to result from astrocyte proliferation (Irons 
et al., 2008). These diverse approaches toward modeling the CNS 
injury environment in vitro are very useful models for exploring 
factors related to neuronal vs glial viability as a function of complex 
culture conditions and cell activation due to injury.
Finally, as biomaterials and bioMEMs scientists continue to 
report new and imaginative means to create 3-D cultures that 
enable manipulation of the concentrations and positions of mul-
tiple cell types as well as soluble cues and insoluble matrix mol-
ecules (Mapili et al., 2005; Arcaute et al., 2006; Khetani and Bhatia, 
2006; Khademhosseini et al., 2007; Papavasiliou et al., 2008; Lee 
et al., 2009), we anticipate great advances in the area of advanced 
in vitro model systems. When combined with a rich background 
of technologies centered on hydrogels and bio-inspired materials 
for cell transplantation and the delivery drugs, proteins and genes 
(Giordano et al., 2008; Murua et al., 2008; Quaglia, 2008; Schmidt 
et al., 2008; Lin and Anseth, 2009; Silva et al., 2009) the time is right 
for applying new knowledge gained from controlled in vitro studies 
toward animal and human neuroprosthetic implants.
ISSUES ON THE FRONTIER: GLEANING FROM DEVELOPMENTAL AND 
CANCER BIOLOGY
Because effective therapies for repairing CNS injuries have remained 
elusive despite decades of extensive research, researchers are exam-
ining this problem from other angles. For example, insights from 
developmental neurobiology on fundamental mechanisms of neu-
ronal cell migration, axonal outgrowth and pathﬁ  nding (guided 
growth to synaptic targets) have yielded knowledge about cues that 
are favorable or inhibitory for axonal growth. Interestingly, these 
inhibitory molecules can also be found in sites of injury in the adult 
CNS (De Winter et al., 2002; Goldshmit et al., 2004; Hashimoto 
et al., 2004). For example, one family of developmental cues, the Eph 
receptors and their ligands, the ephrins, are known mediators of tis-
sue organization during development (for a comprehensive review, 
see Goldshmit et al., 2006). Though the details are not yet under-
stood, there is a link between Eph/ephrin molecules, inﬂ  ammation 
and glial scar, and evidence indicates that Eph/ephrin expression 
and activation play roles in inhibiting neuronal regeneration fol-
lowing injury in the CNS. Therefore, tissue engineering technolo-
gies could be used to explore potential strategies such as controlled 
release of ephrin (via biomaterials or cell-based approaches men-
tioned above) or overexpression of Eph receptors toward the aim 
of guiding neurite growth or mediating inﬂ  ammation and scarring 
in the implant microenvironment. Such developmental cues that 
mediate cell-cell contact or act at a distance through diffusible 
signals provide a wealth of new avenues for exploration using the 
cell/biomolecule patterning tools, controlled release platforms and 
advanced culture models mentioned above.
Another possible source of fresh insight into CNS repair follow-
ing injury comes from the cancer biology ﬁ  eld and their particular 
insight into factors that control cell cycle (Byrnes and Faden, 2007). 
Entry into cell cycle is commonly recognized as the means by which 
cells initiate proliferation, which is the case for mitotic cells, such 
FIGURE 9 | An in vitro model of glial scarring developed by Polikov and 
colleagues (Polikov et al., 2006, 2009) using an optimized cell culture 
monolayer of primary astrocytes and microglia. (A) Upon implantation of a 
50-µm metallic wire into this culture, distinct traits of glial scarring are 
observed, such as microglial (red) activation and attachment to the implanted 
microwires, astrocyte (green) activation beyond the microglial layer in the form 
of GFAP up-regulation and encapsulation of wires by reactive astrocytes. (B) 
Shows the scar phenomena at higher magniﬁ  cation. Reprinted from Polikov 
et al. (2006). Copyright 2006, with permission from Elsevier.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  13
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as astrocytes, microglia and other inﬂ  ammatory cells. Neurons in 
the CNS, however, are post-mitotic (with the exception of NPCs) 
and for these cells, entry into the cell cycle results in apoptosis 
(programmed cell death) (Nguyen et al., 2002; Wartiovaara et al., 
2002; Wang et al., 2009b). Thus, prevention of entry into the cell 
cycle is favorable for both neuronal survival as well as prevention 
of uncontrolled glial scarring and inﬂ  ammation.
Fortunately, entry into the cell cycle and drug candidates that 
may control this response are heavily investigated in the cancer 
biology ﬁ  eld, as uncontrolled proliferation is a hallmark of cancer 
cells. In fact, a recent study (Koprivica et al., 2005) was undertaken 
to screen at least 400 small molecules for their ability to promote 
neurite outgrowth on an inhibitory surface of myelin (a component 
of spinal cord injury scar); the majority of compounds had no effect, 
but several drugs related to inhibiting the epidermal growth fac-
tor receptor (EGFR) were able to block the inhibitory effect of the 
myelin substrate and resulted in robust neurite outgrowth, as shown 
in Figure 11. These effects were corroborated in a mouse model of 
optic nerve injury, resulting in signiﬁ  cant nerve regeneration in 
treated animals compared to control mice without treatment. The 
cellular mechanism behind the effectiveness of EGFR inhibition 
relates to intracellular signaling cascades involving known players 
in cancer biology, including the MAPK, Akt and JNK pathways 
that impact DNA synthesis and cell proliferation (Oda et al., 2005). 
Interestingly, EGFR is not the only mediator of these pathways that 
has been linked to CNS injury (Di Giovanni et al., 2005; Milenkovic 
et al., 2005; Neary and Kang, 2005; Nicole et al., 2005; Kaneko et al., 
2007; Lim et al., 2007) and several molecules that inhibit these path-
FIGURE 10 | Co-culturing meningeal ﬁ  broblasts along with astrocytes 
in vitro can cause astrocyte reactivity and increased GFAP expression 
similar to in vivo glial scarring [157]. (A) Astrocytes (A-ctrl) in 2-D culture 
show perinuclear GFAP reactivity and are ﬂ  at, round, or oval-shaped cells. (B) 
Long-term astrocyte–ﬁ  broblast co-cultures (A + F) show spindle-shaped 
astrocytes with elongated processes surrounded by meningeal ﬁ  broblasts. 
Also observed are astrocytic processes entering ﬁ  broblast territory (arrows) 
and brighter GFAP staining of astrocytes contacting ﬁ  broblasts. (C) Shows a 2-
day mixed culture of astrocytes and ﬁ  broblasts showing strongly GFAP+ 
astrocytes (arrows) on and around patches of ﬁ  broblasts. (D) Shows 
differentiated astrocytes on collagen-coated silastic membranes without the 
presence of ﬁ  bronectin+ cells. (E) Shows astrocyte–ﬁ  broblast co-culture 3 
days following ﬁ  broblast addition and 24 h stretching (A + F-str) show 
disruption of processes, with clusters of star shaped astrocytes forming 
“bridges” of bundled processes across spaces shown as asterisks. Increased 
GFAP signals are found accumulated in stellate processes that are ﬁ  bronectin+ 
(yellow). Fibronectin-positive ﬁ  broblasts (asterisks) remain evenly distributed 
after stretching. Bar = 20 µm. In (A–E), GFAP: green; ﬁ  bronectin: red; nuclei: 
blue). Reprinted from Wanner et al. (2008). Copyright 2008 Wiley-Liss Inc. 
Reproduced with permission.Frontiers in Neuroengineering  www.frontiersin.org  February 2010  | Volume 2  |  Article 18  |  14
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ways are already approved as potential drugs for cancer treatment. 
Thus, a promising and immediately feasible line of research is to test 
these drugs in conjunction with neuroprosthetic devices to promote 
neuronal survival and inhibit scar formation and inﬂ  ammation. This 
approach is particularly  exciting because of the immediate implica-
tions for treatment of CNS injury (Miller, 2005) and like the pos-
sible insights gleaned from developmental biology mentioned above, 
the wealth of knowledge from cancer biology provides potentially 
powerful new avenues of exploration for addressing CNS injuries 
including those associated with neuroprosthetic devices.
CONCLUSIONS
Major advances in neuroprosthetics device design have been 
achieved, yet great challenges remain in controlling the cellular and 
molecular interface between the device and the CNS. Despite suc-
cesses in short-term implant studies, these challenges have barred 
reliable long-term performance in patient implants. We believe that 
current areas of device design innovation, including wireless devices, 
new approaches to minimize device  micro-motion, and novel device 
materials that mimic the mechanics of CNS tissue will further the 
success of these devices. The most signiﬁ  cant advances, however, 
will arise from collaborations on the intersection between the neu-
roprosthetics, tissue engineering and neurobiology ﬁ  elds. Each com-
munity stands to beneﬁ  t from such interactions to yield improved 
model systems,   therapeutic strategies, and quantitative metrics for 
assessing outcomes. We stress the importance of appreciating the 
complexity of the biological response to CNS injury, and speciﬁ  cally, 
response to neuroprosthetic devices that rely on implant type, loca-
tion and other factors. Such responses involve numerous biological 
components that are organized spatially and temporally in a dynamic 
fashion. Multifactorial approaches that address multiple biological 
aims, such as drug delivery and patterning technologies are well-
poised to address these issues related to dynamics and heterogene-
ity. Moreover, tissue-mimetic model systems present test beds with 
greater physiological relevance and complexity and are likely to work 
synergistically with animal studies to more rapidly identify promising 
device technologies. Finally, insights from the   developmental and 
cancer biology ﬁ  elds are providing fresh insights that will yield novel 
mechanisms to inﬂ  uence CNS response to neuroprosthetic implants. 
We look toward the future of neuroprosthetic devices with optimism 
and conﬁ  dence that such interdisciplinary collaborations will lead us 
ever closer toward successful long-term device performance.
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FIGURE 11 | Regeneration of the optic nerve in mice using an EGFR 
blocking molecule, PD168393. Optic nerves stained with antibodies against 
GAP43 compared to controls (A,C) or PD168393-treated (B,D) mice. Lectin 
staining and visual inspection were used to identify the injury site (marked by C). 
The images in (C,D) are magniﬁ  ed views of the post crush area that were 
treated and untreated by PD168393. In (C), the control nerve shows very few 
GAP-43 ﬁ  bers whereas in (D), numerous regenerating ﬁ  bers are observed, 
including some that had changed their direction (ﬁ  lled triangle). Scale 
bar = 100 µm in (A,B) and 50 µm in (C,D). Reprinted from Koprivica et al. (2005). 
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